Amazon.com Inc.’s data center operation is much larger than commonly understood, totaling more than 900 facilities in more than 50 countries, according to documents reviewed by Bloomberg and ...

What happens at the dining table no longer stays at the dining table. If the city’s servers suddenly always seem to know your go-to drink order, or how you always order extra croutons on your salad – ...

Given the myriad risks facing investors these days — from high valuations in the stock market to worries about an AI bubble and beyond — some might be tempted to take their money out of the market and ...

Last month, Trump said U.S. officials would suggest limiting the use of Tylenol during pregnancy, though doctors say it is safe to use. The state of Texas sued Tylenol maker Kenvue on Oct. 28, ...

There are over a thousand planned or existing data centers across the US, according to a BI investigation. Major tech companies are racing to construct even more as the AI boom continues. But at what ...

Microsoft Corp.’s data-center crunch will continue for longer than the company has previously outlined, underscoring the software giant’s struggles to keep up with cloud demand. Many of Microsoft’s US ...

Health Care Providers Are Dropping a Common Anesthesia Drug That’s Also a Climate Super Pollutant Ten Million Corals Are in the Path of a Federal Dredging Project in Florida Why New York City Is ...

What if building powerful, data-driven workflows no longer required juggling multiple tools or worrying about connectivity issues? With the introduction of native data tables, n8n has redefined what’s ...

WASHINGTON, Sept 9 (Reuters) - The U.S. Justice Department is in talks with Homeland Security Investigations about transferring the sensitive voter roll data it has collected from states for use in ...

“Today, the BLS released the largest downward revision on record proving that President Trump was right: Biden’s economy was a disaster and the BLS is broken. This is exactly why we need new ...

Industry watchers who cheered on Summit Therapeutics’ claim that the first global phase 3 trial of its Akeso-partnered PD-1xVEGF drug showed consistent benefit between China and Western populations ...